Want to see HK:1466 full AI Analyst Report?

Affluent Partners Holdings (1466) Price & Analysis

0 Followers

1466 Stock Chart & Stats

HK$0.77

-HK$0.03(-3.00%)

At close: Jul 27 4:00 PM EDT

HK$0.77

-HK$0.03(-3.00%)

Day’s Range― - ―

52-Week RangeHK$0.47 - HK$1.96

Previous CloseN/A

Volume490.00K

Average Volume (3M)2.77M

Market Cap

HK$1.77B

Enterprise ValueHK$487.53

Total Cash (Recent Filing)HK$43.11M

Total Debt (Recent Filing)HK$28.41M

Price to Earnings (P/E)―

Beta-1.16

Next Earnings

Nov 26, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.06

Shares Outstanding932,254,100

10 Day Avg. Volume3,092,500

30 Day Avg. Volume2,769,310

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)2.69

Price to Sales (P/S)5.57

P/FCF Ratio-22.06

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

DeleveragingThe substantial reduction in debt relative to equity strengthens financial flexibility and lowers balance-sheet strain. A lighter debt burden can reduce exposure to financing pressure, preserve capacity for operations, and improve resilience while the company works to restore profitability.

Balance-Sheet ResilienceA sizeable equity base relative to total assets provides an important buffer against operating losses and supports solvency. This capital structure gives the company more ability to absorb continued earnings volatility than a balance sheet dependent on heavy borrowing.

Historical Profitability PotentialProfitability in 2023 shows that the business has previously been capable of producing earnings, providing evidence of underlying profit potential rather than a permanently loss-making history. However, the irregular record means this remains an opportunity, not yet a dependable strength.

Bears Say

Revenue ContractionThe sharp revenue decline indicates weakening business activity and reduces the scale over which fixed costs can be spread. If sustained, contraction would make recovery harder, limit internal investment capacity, and increase the importance of restoring demand and operating momentum.

Deepening LossesDeeply negative net margins show that current operations are not converting revenue into shareholder returns. The deterioration from near break-even losses in 2025 signals weak operating leverage and leaves earnings highly dependent on a substantial improvement in costs, pricing, or revenue.

Persistent Cash BurnRepeatedly negative operating cash flow indicates that the core business has not consistently funded itself. Negative free cash flow adds pressure because cash remains depleted after investment, increasing funding risk and potentially limiting the company’s ability to pursue growth while losses persist.

Affluent Partners Holdings News

Baijin Life Science Wins Full Shareholder Backing at AGM

Affluent Partners Holdings ( ($HK:1466) ) just unveiled an update. Shareholders of Baijin Life Science Holdings Limited unanimously...

17d ago

Baijin Life Science Sets 2026 AGM to Approve Accounts, Board Mandates and Share Issuance Authority

The latest update is out from Affluent Partners Holdings ( ($HK:1466) ). Baijin Life Science Holdings has convened...

1M ago

Baijin Life Science Swings to Deep Annual Loss as Revenue Falls

An update from Affluent Partners Holdings ( ($HK:1466) ) is now available. Baijin Life Science Holdings reported a...

3M ago

Baijin Life Science Warns of Sharply Wider Annual Loss

Affluent Partners Holdings ( ($HK:1466) ) has issued an update. Baijin Life Science Holdings has issued a profit...

3M ago

Baijin Life Science says China Water liquidation has no impact on its operations

The latest announcement is out from Affluent Partners Holdings ( ($HK:1466) ). Baijin Life Science Holdings has disclosed...

4M ago

Baijin Life Science Sets Board Meeting to Approve 2026 Results and Mull Final Dividend

Affluent Partners Holdings ( ($HK:1466) ) just unveiled an update. Baijin Life Science Holdings has scheduled a board...

4M ago

Baijin Life Science Signs Framework Deal for Clinical Cell Therapy Collaboration

Affluent Partners Holdings ( ($HK:1466) ) has provided an update. Baijin Life Science Holdings has announced that its...

5M ago

Baijin Life Science Grants 67.9 Million Share Options to Directors and Staff

The latest announcement is out from Affluent Partners Holdings ( ($HK:1466) ). Baijin Life Science Holdings has granted...

5M ago

Baijin Life Science Adds Independent Director to Restore Governance Compliance

Affluent Partners Holdings ( ($HK:1466) ) has shared an update. Baijin Life Science Holdings has appointed Ms. Shen...

7M ago

Baijin Life Science Clarifies Board and Committee Roles in Governance Update

An announcement from Affluent Partners Holdings ( ($HK:1466) ) is now available. Baijin Life Science Holdings has released...

7M ago

1466 FAQ

What was Affluent Partners Holdings Ltd’s price range in the past 12 months?

Affluent Partners Holdings Ltd lowest stock price was HK$0.47 and its highest was HK$1.96 in the past 12 months.

What is Affluent Partners Holdings Ltd’s market cap?

Affluent Partners Holdings Ltd’s market cap is HK$1.77B.

When is Affluent Partners Holdings Ltd’s upcoming earnings report date?

Affluent Partners Holdings Ltd’s upcoming earnings report date is Nov 26, 2026 which is in 54 days.

How were Affluent Partners Holdings Ltd’s earnings last quarter?

Affluent Partners Holdings Ltd released its earnings results on Jun 30, 2026. The company reported -HK$0.048 earnings per share for the quarter.

Is Affluent Partners Holdings Ltd overvalued?

According to Wall Street analysts Affluent Partners Holdings Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Affluent Partners Holdings Ltd pay dividends?

Affluent Partners Holdings Ltd does not currently pay dividends.

What is Affluent Partners Holdings Ltd’s EPS estimate?

Affluent Partners Holdings Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Affluent Partners Holdings Ltd have?

Affluent Partners Holdings Ltd has 932,254,100 shares outstanding.

What happened to Affluent Partners Holdings Ltd’s price movement after its last earnings report?

Affluent Partners Holdings Ltd reported an EPS of -HK$0.048 in its last earnings report. Following the earnings report the stock price went down -19.231%.

Which hedge fund is a major shareholder of Affluent Partners Holdings Ltd?

Currently, no hedge funds are holding shares in HK:1466

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Affluent Partners Holdings Ltd

Affluent Partners Holdings Limited, an investment holding entity founded in 2014 and situated in Central, Hong Kong, conducts various operations. Its core business involves the full lifecycle of pearls and jewelry products, including their acquisition, processing, design, manufacturing, assembly, trading, and wholesale distribution. The company's activities are structured into two distinct divisions: the sale of pearl and jewelry items, and strategic investment alongside financial services. Additionally, it allocates capital to financial assets within the real estate sector. Affluent Partners operates internationally, with a footprint in Hong Kong, the United Kingdom, the United States, Japan, Europe, and mainland China. This enterprise was previously known as Man Sang Jewellery Holdings Limited, undergoing a name change to Affluent Partners Holdings Limited in February 2017.